· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Лечебное дело 2023 / N 4 Собственные клинико-фармакологические эффекты гесперидина в лечении хронических заболеваний вен Е.В. Ших, Е.Д. Хайтович Список литературы/References 1. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018;12(3):146-240. [Russian clinical guidelines for the diagnostics and treatment of chronic venous diseases. Flebologiya. 2018;12(3):146-240. (In Russ.).] DOI: 10.17116/flebo20187031146 2. Robertson L, Evans C, Fowkes FGR. Epidemiology of chronic venous disease. Phlebology. 2008;23(3):103-111. DOI: 10.1258/phleb.2007.007061 3. Максимов М.Л., Ермолаева А.С., Вознесенская А.А., Стародубцев А.К. Хронические заболевания вен: особенности патогенеза и рациональные подходы к терапии. Русский медицинский журнал. 2018;2(4):25-29. [Maksimov ML, Yermolayeva AS, Voznesenskaya A.A., Starodubtsev A.K. Chronic venous diseases: features of pathogenesis and rational approaches to therapy. Russian Medical Journal. 2018;2(4):25-29. (In Russ.).] 4. Man MQ, Yang B, Elias PM. Benefits of hesperidin for cutaneous functions. Evidence-Based Complementary and Alternative Medicine. 2019;2019:2676307. DOI: 10.1155/2019/2676307 5. Tripoli E, La Guardia M, Giammanco S, Di Majo D, Giammanco M. Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review. Food Chemistry. 2007;104(2):466-479. DOI: 10.1016/j.foodchem.2006.11.054 6. Karetová D, Suchopár J, Bultas J. Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only? Vnitrní Lékarství. 2020 Spring;66(2):97-103. DOI: PMID: 32942884 7. Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytotherapy Research. 2014;29(3):323-331. DOI: 10.1002/ptr.5256 8. Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020;12(2):457. DOI: 10.3390/nu12020457 9. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota. Journal of Physiology and Pharmacology. 2012;63(5):497-503. PMID: 23211303. 10. Assini JM, Mulvihill EE, Huff MW. Citrus flavonoids and lipid metabolism. Current Opinion in Lipidology. 2013;24(1):34-40. DOI: 10.1097/MOL.0b013e32835c07fd 11. Saxena RK, Vallyathan V, Lewis DM. Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells. Journal of Biosciences. 2003;28(1):129-134. DOI: 10.1007/BF02970143 12. Kim HJ, Jeon SM, Lee MK, Cho YY, Kwon EY, Lee JH, Choi MS. Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters. Journal of Medicinal Food. 2010;13(4):808-814. DOI: 10.1089/jmf.2009.1320 13. Yang HL, Chen SC, Senthil Kumar KJ, Yu KN, Lee Chao PD, Tsai SY, Hou YC, Hseu YC. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach. Journal of Agricultural and Food Chemistry. 2012;60(1):522-532. DOI: 10.1021/jf2040675 14. Jeon HJ, Seo MJ, Choi HS, Lee OH, Lee BY. 2014. Gelidium elegans, an edible red seaweed, and hesperidin inhibit lipid accumulation and production of reactive oxygen species and reactive nitrogen species in 3 T3-L1 and RAW264.7 cells. Phytotherapy Research. 2014;28(11):1701-1709. DOI: 10.1002/ptr.5186 15. Li R, Li J, Cai L, Hu CM, Zhang L. Suppression of adjuvant arthritis by hesperidin in rats and its mechanisms. The Journal of Pharmacy and Pharmacology. 2008;60(2):221-228. DOI: 10.1211/jpp.60.2.0011 16. Li R, Li J, Hu CM, Zhang L, Jiang H. Therapeutic effect of hesperidin on adjuvant arthritis in rats and its mechanisms. Chinese Pharmacological Bulletin. 2008;24:494-498. 17. Li R, Cai L, Xie XF, Yang F, Li J. Hesperidin suppresses adjuvant arthritis in rats by inhibiting synoviocyte activity. Phytotherapy Research. 2010;24(Suppl. 1):S71-S76. DOI: 10.1002/ptr.2906 18. Li D, Mitsuhashi S, Ubukata M. Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation. Pharmaceutical Biology. 2012;50(12):1531-1535. DOI: 10.3109/13880209.2012.694106 19. Li R, Cai L, Ren DY, Xie XF, Hu CM, Li J. Therapeutic effect of 7,3’-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway. International Immunopharmacology. 2012;14(2):157-163. DOI: 10.1016/j.intimp.2012.07.001 20. Li R, Cai L, Xie XF, Peng L, Wu TN, Li J. 7,3’-dimethoxy hesperetin inhibits inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis. Immunopharmacology and Immunotoxicology. 2013;35(1):139-146. DOI: 10.3109/08923973.2012.723010 21. Kometani T, Fukuda T, Kakuma T, Kawaguchi K, Tamura W, Kumazawa Y, Nagata K. Effects of α-glucosylhesperidin, a bioactive food material, on collagen-induced arthritis in mice and rheumatoid arthritis in humans. Immunopharmacology and Immunotoxicology. 2008;30(1):117-134. DOI: 10.1080/08923970701812688 22. Kim JY, Jung KJ, Choi JS, Chung HY. Hesperetin: a potent antioxidant against peroxynitrite. Free Radical Research. 2004;38(7):761-769. DOI: 10.1080/10715760410001713844 23. Kim SH, Kim BK, Lee YC. Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. Mediators of Inflammation. 2011;2011:485402. DOI: 10.1155/2011/485402 24. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998;9(5):745-755. DOI: 10.1016/s1074-7613(00)80671-8 25. Tian MM, Li YX, Liu S, Zhu CH, Lan XB, Du J, Ma L, Yang JM, Zheng P, Yu JQ, Liu N. Glycosides for peripheral neuropathic pain: potential medicinal components. Molecules (Basel, Switzerland). 2022;27:255. DOI: 10.3390/molecules27010255 26. MacCarthy EP, Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy. 1983;3(4):193-219. DOI: 10.1002/j.1875-9114.1983.tb03252.x 27. Общая характеристика лекарственного препарата. Детралекс. Ссылка активна на 06.12.2023. [General characteristics of the drug. Detralex. (In Russ.).] chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://servier.ru/wp-content/uploads/2018/10/20201222-SmPC-RU-Detralex-os-ru-1.pdf 28. Ramelet AA. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology. 2001;52(Suppl. 1):S49-S56. DOI: 10.1177/0003319701052001S07 29. Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Pharmacology of diosmin, a citrus flavone glycoside: an updated review. European Journal of Drug Metabolism and Pharmacokinetics. 2022;47(1):1-18. DOI: 10.1007/s13318-021-00731-y 30. Perrin M, Guex JJ. Edema and leg volume: methods of assessment. Angiology. 2000;51(1):9-12. DOI: 10.1177/000331970005100103 31. Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Quality of Life Research. 1996;5(6):539-554. DOI: 10.1007/BF00439228 32. Ali MY, Jannat S, Jung HA, Choi JS. Structural bases for hesperetin derivatives: inhibition of protein tyrosine phosphatase 1B, kinetics mechanism and molecular docking study. Molecules (Basel, Switzerland). 2021;26(24):7433. DOI: 10.3390/molecules26247433 33. Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, Quon MJ. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism. 2011;96(5):E782-E792. DOI: 10.1210/jc.2010-2879 34. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, Mazur A. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. The American Journal of Clinical Nutrition. 2010;93(1):73-80. DOI: 10.3945/ajcn.110.004945 35. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition. 2004;79(5):727-747. DOI: 10.1093/ajcn/79.5.727 36. Ameer B, Weintraub RA, Johnson JV, Yost RA, Rouseff RL. Flavanone absorption after naringin, hesperidin, and citrus administration. Clinical Pharmacology & Therapeutics. 1996;60(1):34-40. DOI: 10.1016/S0009-9236(96)90164-2 37. Ding Z, Sun G, Zhu Z. Hesperidin attenuates influenza A virus (H1N1) induced lung injury in rats through its anti‑inflammatory effect. Antiviral Therapy. 2018;23(7):611-615. DOI: 10.3851/IMP3235 38. Lee HJ, Im AR, Kim SM, Kang HS, Lee JD, Chae S. The flavonoid hesperidin exerts anti‑photoaging effect by downregulating matrix metalloproteinase (MMP)‑9 expression via mitogen activated protein kinase (MAPK)‑dependent signaling pathways. BMC Complementary and Alternative Medicine. 2018;18(1):39. DOI: 10.1186/s12906‑017‑2058‑8 39. Tejada S, Pinya S, Martorell M, Capó X, Tur JA, Pons A, Sureda A. Potential anti‑inflammatory effects of hesperidin from the genus citrus. Current Medicinal Chemistry. 2018;25(37):4929-4945. DOI: 10.2174/0929867324666170718104412 40. Sakata K, Hirose Y, Qiao Z, Tanaka T, Mori H. Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Letters. 2003;199(2):139-145. DOI: 10.1016/s0304-3835(03)00386-0 41. Huang Y, Ho S. Polymethoxy flavones are responsible for the anti-inflammatory activity of citrus fruit peel. Food Chemistry. 2010;119:868-873. DOI: 10.1016/j.foodchem.2009.09.092 42. Hirata A, Murakami Y, Shoji M, Kadoma Y, Fujisawa S. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Research. 2005;25(5):3367-3374. PMID: 16101151 43. Kazłowska K, Hsu T, Hou CC, Yang WC, Tsai GJ. Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentata. Journal of Ethnopharmacology. 2010;128(1):123-130. DOI: 10.1016/j.jep.2009.12.037 44. Lee JH, Kim GH. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. Journal of Food Science. 2010;75(7):H212-H217. DOI: 10.1111/j.1750-3841.2010.01755.x 45. Kang SR, Park K, Park HS, Lee DH, Kim JA, Nagappan A, Kim EH, Lee WS, Shin SH, Park MK, Han DH, Kim GS. Anti-inflammatory effect of flavonoids isolated from Korea Citrus aurantium L. on lipopolysaccharide-induced mouse macrophage RAW 264.7 cells by blocking of nuclear factor-kappa B (NF-kB) and mitogen-activated protein kinase (MAPK) signalling pathways. Food Chemistry. 2011;129(4):1721-1728. DOI: 10.1016/j.foodchem.2011.06.039 46. Choi IY, Kim SJ, Jeong HJ, Park SH, Song YS, Lee JH, Kang TH, Park JH, Hwang GS, Lee EJ, Hong SH, Kim HM, Um JY. Hesperidin inhibits expression of hypoxia inducible factor-1 alpha and inflammatory cytokine production from mast cells. Molecular and Cellular Biochemistry. 2007;305(1-2):153-161. DOI: 10.1007/s11010-007-9539-x 47. Yeh CC, Kao SJ, Lin CC, Wang SD, Liu CJ, Kao ST. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sciences. 2007;80(20):1821-1831. DOI: 10.1016/j.lfs.2007.01.052 48. Zielińska-Przyjemska M, Ignatowicz E. Citrus fruit flavonoids influence on neutrophil apoptosis and oxidative metabolism. Phytotherapy Research. 2008;22(12):1557-1562. DOI: 10.1002/ptr.2449 49. Ho SC, Kuo CT. Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium). Food & Chemical Toxicology. 2014;71:176-182. DOI: 10.1016/j.fct.2014.06.014 50. Nizamutdinova IT, Jeong JJ, Xu GH, Lee SH, Kang SS, Kim YS, Chang KC, Kim HJ. Hesperidin, hesperidin methyl chalone and phellopterin from Poncirus trifoliata (Rutaceae) differentially regulate the expression of adhesion molecules in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells. International Immunopharmacology. 2008;8(5):670-678. DOI: 10.1016/j.intimp.2008.01.011 51. Kim SW, Kim CE, Kim MH. Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. Biochemical and Biophysical Research Communications. 2011;415(4):602-607. DOI: 10.1016/j.bbrc.2011.10.115 52. Yamamoto M, Jokura H, Hashizume K, Ominami H, Shibuya Y, Suzuki A, Hase T, Shimotoyodome A. Hesperidin metabolite hesperetin-7-O-glucuronide, but not hesperetin-3’-O-glucuronide, exerts hypotensive, vasodilatory, and anti-inflammatory activities. Food & Function. 2013;4:1346-1351. DOI: 10.1039/c3fo60030k 53. Moon PD, Kim HM. Antiinflammatory effects of traditional Korean medicine, JinPi-tang and its active ingredient, hesperidin in HaCaT cells. Phytotherapy Research. 2012;26:657-662. DOI: 10.1002/ptr.3627 54. Fu S, Sun C, Tao X, Ren Y. Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Natural Product Research. 2012;26:1746-1749. DOI: 10.1080/14786419.2011.608675 55. Wei D, Ci X, Chu X, Wei M, Hua S, Deng X. Hesperidin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model. Inflammation. 2012;35(1):114-121. DOI: 10.1007/s10753-011-9295-7 56. Raza SS, Khan MM, Ahmad A, Ashafaq M, Khuwaja G, Tabassum R, Javed H, Siddiqui MS, Safhi MM, Islam F. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Research. 2011;1420:93-105. DOI: 10.1016/j.brainres.2011.08.047 57. Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R, Jha KA. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvascular Research. 2013;87:65-74. DOI: 10.1016/j.mvr.2013.01.002 58. Hong Y, An Z. Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-kappaB signaling. Archives of Pharmacal Research. 2018;41(6):655-663. DOI: 10.1007/s12272-015-0662-z 59. Rotelli AE, Guardia T, Juárez AO, de la Rocha NE, Pelzer LE. Comparative study of flavonoids in experimental models of inflammation. Pharmacological Research. 2003;48(6):601-606. DOI: 10.1016/s1043-6618(03)00225-1 60. Ahmed YM, Messiha BA, Abo-Saif AA. Protective effects of simvastatin and hesperidin against complete Freund’s adjuvant-induced rheumatoid arthritis in rats. Pharmacology. 2015;96(5-6):217-225. DOI: 10.1159/000439538 61. Monforte MT, Trovato A, Kirjavainen S, Forestieri AM, Galati EM, Lo Curto RB. Biological effects of hesperidin, a Citrus flavonoid. (note II): hypolipidemic activity on experimental hypercholesterolemia in rat. Farmaco. 1995;50(9):595-599. PMID: 7495469 62. Shi X, Liao S, Mi H, Guo C, Qi D, Li F, Zhang C, Yang Z. Hesperidin prevents retinal and plasma abnormalitie in streptozotocin-induced diabetic rats. Molecules (Basel, Switzerland). 2012;17(11):12868-12881. DOI: 10.3390/molecules171112868 63. El-Marasy SA, Abdallah HM, El-Shenawy SM, El-Khatib AS, El-Shabrawy OA, Kenawy SA. Antidepressant effect of hesperidin in diabetic rats. Canadian Journal of Physiology and Pharmacology. 2014;92(11):945-952. DOI: 10.1139/cjpp-2014-0281 64. Koyuncu H, Berkarda B, Baykut F, Soybir G, Alatli C, Gül H, Altun M. Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter. Anticancer Research. 1999;19(41):3237-3241. PMID: 10652617 65. Tanaka T, Tanaka T, Tanaka M, Kuno T. Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin. Journal of Biomedicine & Biotechnology. 2012;2012:516981. DOI: 10.1155/2012/516981 66. Saiprasad G, Chitra P, Manikandan R, Sudhandiran G. Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice. Inflammation Research. 2013;62(4):425-440. DOI: 10.1007/s00011-013-0595-2 67. Siddiqi A, Hasan SK, Nafees S, Rashid S, Saidullah B, Sultana S. Chemopreventive efficacy of hesperidin against chemically induced nephrotoxicity and renal carcinogenesis via amelioration of oxidative stress and modulation of multiple molecular pathways. Experimental and Molecular Pathology. 2015;99(3):641-653. DOI: 10.1016/j.yexmp.2015.11.012 68. Mahmoud AM. Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPAR-γ and abrogation of oxidative stress and inflammation. Canadian Journal of Physiology and Pharmacology. 2014;92(2):717724. DOI: 10.1139/cjpp-2014-0204 69. Sahu BD, Kuncha M, Sindhura GJ, Sistla R. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine. 2013;20(5):453-460. DOI: 10.1016/j.phymed.2012.12.001 70. Petrova A, Davids LM, Rautenbach F, Marnewick JL. Photoprotection by honeybush extracts, hesperidin and mangiferin against UVB-induced skin damage in SKH-1 mice. Journal of Photochemistry and Photobiology B: Biology. 2011;103(2):126-139. DOI: 10.1016/j.jphotobiol.2011.02.020 71. de Oliveira CA, Peres DDA, Rugno CM, Kojima M, Pinto CASO, Consiglieri VO, Kaneko TM, Rosado C, Mota J, Velasco MVR, Baby A. Functional photostability and cutaneous compatibility of bioactive UVA sun care products. Journal of Photochemistry and Photobiology B: Biology. 2015;148:154-159. DOI: 10.1016/j.jphotobiol.2015.04.007 72. Yeh YH, Hsieh YL, Lee YT. Effects of yam peel extract against carbon tetrachloride-induced hepatotoxicity in rats. Journal of the Agricultural and Food Chemistry. 2013;61(30):7387-7396. DOI: 10.1021/jf401864y 73. Park HY, Choi HD, Eom H, Choi I. Enzymatic modification enhances the protective activity of citrus flavonoids against alcohol-induced liver disease. Food Chemistry. 2013;139(1-4):231-240. DOI: 10.1016/j.foodchem.2013.01.044 74. Milenkovic D, Deval C, Dubray C, Mazur A, Morand C. Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One. 2011;6(11):e26669. DOI: 10.1371/journal.pone.0026669 75. Perche O, Vergnaud-Gauduchon J, Morand C, Dubray C, Mazur A, Vasson MP. Orange juice and its major polyphenol hesperidin consumption do not induce immunomodulation in healthy well-nourished humans. Clinical Nutrition (Edinburgh, Scotland). 2014;33(1):130-135. DOI: 10.1016/j.clnu.2013.03.012 76. Haidari F, Heybar H, Jalali MT, Ahmadi Engali K, Helli B, Shirbeigi E. Hesperidin supplementation modulates inflammatory responses following myocardial infarction. Journal of the American College of Nutrition. 2015;34(3):205-211. DOI: 10.1080/07315724.2014.891269 77. Feldo M, Woźniak M, Wójciak-Kosior M, Sowa I, Kot-Waśik A, Aszyk J, Bogucka-Kocka A. Influence of diosmin treatment on the level of oxidative stress markers in patients with chronic venous insufficiency. Oxidative Medicine and Cellular Longevity. 2018;2018:2561705. DOI: 10.1155/2018/2561705 78. Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Венарус® ЛП-№(001505)-(РГ-RU). Ссылка активна на 24.11.2023. [State Register of Medicine. Instructions for the medical use of the drug Venarus® LP-No.(001505)-(RG-RU). (In Russ.).] https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routingGuid=c49bf283-7e56-473e-9bcd-7b663e94e4d8 79. Гурфинкель Ю.И., Сасонко М.Л., Талов Н.А. Коррекция параметров микроциркуляции крови и функции эндотелия при хронической венозной недостаточности нижних конечностей. Ангиология и сосудистая хирургия. 2017;23(2):89-94. [Gurfinkel YuI, Sasonko ML, Talov NA. Correction of blood microcirculation parameters and endothelial function in chronic venous insufficiency of the lower limbs. Angiology and Vascular Surgery. 2017;23(2):89-94. (In Russ.).] 80. Калинин Р.Е., Сучков И.А., Камаев А.А., Звягина В.И., Крылов А.А. Эндотелиальные эффекты венотонизирующих препаратов при лечении больных с варикозной болезнью. Ангиология и сосудистая хирургия. 2018;24(4):72-77. [Kalinin RE, Suchkov IA, Kamayev AA, Zvyagina VI, Krylov AA. Endothelial effects of venotonic drugs in treatment of patients with varicose veins. Angiology and Vascular Surgery. 2018;24(4):72-77. (In Russ.).] 81. Стойко Ю.М., Гудымович В.Г. Мониторинг качества жизни у больных варикозной болезнью вен нижних конечностей с использованием препарата венарус. Хирургия. Журнал им. Н.И. Пирогова. 2010;6:46-51. [Stoyko YuM, Gudymovich VG. Quality of life monitoring in patients with lower limb varicose vein disease using the drug venarus. Pirogov Russian Journal of Surgery. 2010;6:46-51. (In Russ.).] 82. Araujo-León JA, Ortiz-Andrade R, Hernández-Baltazar E, Hernández-Núñez E, Rivera-Leyva JC, Yáñez-Pérez V, Vazquez-Garcia P, Cicero-Sarmiento CG, Sánchez-Salgado JC, Segura-Campos MR. A pharmacokinetic study of Mix-160 by LC-MS/MS: oral bioavailability of a dosage form of citroflavonoids mixture. Molecules (Basel, Switzerland). 2022;27(2):391. DOI: 10.3390/ molecules27020391 83. Russo R, Chandradhara D, De Tommasi N. Comparative bioavailability of two diosmin formulations after oral administration to healthy volunteers. Molecules (Basel, Switzerland). 2018;23(9):2174. DOI: 10.3390/molecules23092174 84. Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR, Pearce CG, Upchurch GR, Wakefield TW, Henke PK. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. Journal of Vascular Surgery. 2005;42(1):140-148. DOI: 10.1016/j.jvs.2005.04.014    [ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]